Wikidata

(Q64716627)

English

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
INNOVATE-PCI (English)
0 references
title
A Randomized, Double-Blind, Active-Controlled Trial to Evaluate Intravenous and Oral PRT060128, a Selective and Reversible P2Y12 Inhibitor, vs Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent PCI (English)
0 references
country
Austria
0 references
Canada
0 references
Germany
0 references
Poland
0 references
start time
December 2008
0 references
end time
April 2010
0 references
number of participants
652
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64716627&oldid=1857986651"